Suchergebnisse - "P188ANX8CK"

PubPharm (9.107)

1

A Multifunctional Bimetallic Nanoplatform for Synergic Local Hyperthermia and Chemotherapy Targeting HER2-Positive Breast Cancer

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Zhao, L. | Chang, F. | Tong, Y. | +5

2

Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast Cancers

enthalten in: Monoclonal antibodies in immunodiagnosis and immunotherapy | 2024

von Kaneko, M. | Suzuki, H. | Kato, Y.

ErratumIn: Monoclon Antib Immunodiagn Immunother. 2024 Apr 16;:. - PMID 38625004

3

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01) : primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Smit, E. | Felip, E. | Uprety, D. | +17

4

Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet

enthalten in: Anticancer research | 2024

von Sato, M. | Han, Q. | Mori, R. | +7

5

Fe3O4-Cy5.5-trastuzumab magnetic nanoparticles for magnetic resonance/near-infrared imaging targeting HER2 in breast cancer

enthalten in: Biomedical materials (Bristol, England) | 2024

von Yin, Q. | Gao, X. | Zhang, H. | +5

6

Chinese expert consensus on the management of clinical pathway and adverse events of trastuzumab deruxtecan (2024 edition)

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2024

von Trastuzumab Deruxtecan Clinical Management Pathway and Adverse Reaction Management Consensus Expert Group

7

Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer : A Multicenter, Single-Arm, Prospective Study

enthalten in: Cancer research and treatment | 2024

von Jiang, K. | Hong, R. | Xia, W. | +14

8

A low-temperature SPR-based assay for monoclonal antibody galactosylation and fucosylation assessment using FcγRIIA/B

enthalten in: Biotechnology and bioengineering | 2024

von Gaudreault, J. | Forest-Nault, C. | Gilbert, M. | +3

9

NSABP FB-10 : a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer

enthalten in: Breast cancer research : BCR | 2024

von Jacobs, S. | Wang, Y. | Abraham, J. | +18

10

HER2 targeted therapy in colorectal Cancer : Current landscape and future directions

enthalten in: Biochemical pharmacology | 2024

von Chen, N. | He, L. | Zou, Q. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[911]